Putnam Investments’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Putnam Investments’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-258,826	Closed	-$4.83M	–	1254
2022 Q1	$4.83M	Sell	258,826 -5,140	-2%	-$92.5K	0.01%	511
2021 Q4	$5.65M	Buy	263,966 +77,619	+42%	+$1.53M	0.01%	500
2021 Q3	$3.44M	Hold	186,347	–	–	0.01%	644
2021 Q2	$3.99M	Hold	186,347	–	–	0.01%	574
2021 Q1	$3.6M	Buy	+186,347	New	+$3.28M	0.01%	575

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Putnam Investments's OCDX Position: Q2 2022 in Review

Putnam Investments sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 258,826 shares — an estimated $4.83M sold.

Putnam Investments first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $5.65M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Putnam Investments reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Putnam Investments sold 258,826 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $4.83M.
Putnam Investments first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Putnam Investments's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $5.65M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Putnam Investments's 13F filing for Q2 2022, filed 15 Aug 2022.